Sponsor:
Massachusetts General Hospital
Code:
NCT06412172
Conditions
Recurrent Respiratory Papillomatosis
Pulmonary Neoplasm
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Recurrent Respiratory Papillomatosis
Pulmonary Neoplasm
Study ID
NCT06412172
Start date
Apr 15, 2024
Status verified date
Aug, 2025
Completion date
Apr 15, 2030
Anticipated
Primary completion date
Apr 14, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Primary outcome measure
Central contacts
Marcelle Stiff
mstiffpulmonary@rrpf.orgLocations
Yale School of Medicine
Recruiting
New Haven, Connecticut, United States, 06520
Sponsor
Massachusetts General Hospital
Last update posted
Aug 12, 2025
Last verified
Aug, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-08-12.